Overall, we identified CtBP2 as a downstream transcriptional target of CYR61, and demonstrated that CtBP2 expression is required for CYR61-dependent pro-metastatic dissemination of osteosarcoma, by favoring cell migration and invasiveness. The gene discussed is CCN1; the disease is osteosarcoma.